A Phase I Double-Blind Study to Evaluate the Safety and Immunogenicity of HIV Prime/Boost Vaccine Using DNA and MVA for HIV-1/AIDS
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HIV DNA vaccine (Primary) ; MVA HIV vaccine (Primary)
- Indications Acquired immunodeficiency syndrome; HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics
- 10 Jul 2013 New trial record
- 20 Jun 2013 Biomarkers information updated